A computer algorithm can efficiently find genetic mutations that work together to drive cancer as well as other important genetic clues that researchers might someday use to develop new treatments for a variety of cancers.
Sep 11, 2024
0
0
Cancer cells are driven by the same imperative guiding all living things: to grow, survive and reproduce. Although cancer's evolutionary underpinnings have been recognized since the 1950s, clinicians have been slow to apply ...
Sep 11, 2024
0
10
Many clinical trials of new cancer drugs may be inappropriately excluding some people with "Duffy-null phenotype," a trait found predominantly in people of African or Middle Eastern descent, researchers at Dana-Farber Cancer ...
Sep 11, 2024
0
2
A new federal rule takes effect Tuesday that could potentially help more women spot breast cancer earlier. The FDA will require mammogram providers across the country to notify women if they have dense breast tissue, and ...
Sep 11, 2024
0
0
Hopes were high a decade ago, when a new class of drugs called BET inhibitors emerged for treating blood cancers and solid tumors. Since then, however, results from numerous clinical trials have painted a much more complex ...
Sep 10, 2024
0
17
In a study from Huntsman Cancer Institute at the University of Utah (the U) and NYU Langone Perlmutter Cancer Center, researchers found that a specialized chatbot can effectively assist patients in deciding whether to pursue ...
Sep 10, 2024
0
50
Bioactive glasses, a filling material which can bond to tissue and improve the strength of bones and teeth, has been combined with gallium to create a potential treatment for bone cancer.
Sep 10, 2024
0
2
A new report from the Nordic Expert Group (NEG) and the Dutch Expert DECOS committee has evaluated the health hazards and calculated cancer risk of occupational exposure to respirable crystalline silica (RCS). Several experts ...
Sep 10, 2024
0
0
Cholangiocarcinoma (CCA) or bile duct cancer, is a rare, aggressive liver cancer with a poor prognosis, which occurs mostly in people older than age 50. It is often diagnosed when it is advanced, making successful treatment ...
Sep 10, 2024
0
0
The ROS1 tyrosine kinase inhibitor (TKI) taletrectinib demonstrated high overall and intracranial responses, and a favorable safety profile with low incidence of neurologic adverse events in TKI-naive and TKI-pretreated patients ...
Sep 10, 2024
0
0
